We’re Apprentice, your partner in making medicine

Learn how we’re helping manufacturers adopt the latest technologies to make breakthrough therapeutics available to all.

Our story

Despite incredible therapeutic innovations, the process for manufacturing these life-changing drugs lagged behind.

Because of the largely paper-based processes involved in pharma manufacturing, millions of dollars were lost in drug batches due to quality deviations. These legacy processes just weren’t going to hold up to the demands of new therapies – biologics, cell, and gene.

We created Apprentice to bring the pharma industry up to speed with the transformative potential of technology.

Our co-founders, Angelo Stracquatanio, Gary Pignata and Alexandra Buttke come from the worlds of tech and pharma. Together, they've established an international team of experts, a rapidly-expanding customer base, and a growing list of high-caliber partners all dedicated to developing expeditious ways to create medicines that will forever make life better for the people who need them most – patients.

January 2014

Co-founders met and identified how modern technology could solve the inefficiencies in the drug production process.

December 2017

First customers successfully used our web portal and wearable headset to connect remote colleagues to the manufacturing suite and we raised a $2.5 million seed round.

December 2018

Raised an $8 million Series A round to meet the demands of a growing, global customer base and expand product capabilities.

March to November 2020

The COVID-19 pandemic hit and we helped our customers keep drug production going, leading to a $24 million Series B round to keep pace with exploding customer demand.

January 2022

Raised a $100 million Series C round and launched our vision for one platform to turn molecules into medicine.